Novigenix, RadioMedix to develop diagnostic test for neuroendocrine cancer
Novigenix will develop an immune-transcriptomic based precision diagnostic test using its LITOseek platform to assess the effectiveness of…
14 Oct 19
Novigenix will develop an immune-transcriptomic based precision diagnostic test using its LITOseek platform to assess the effectiveness of…
11 Oct 19
EVD, which is caused by the Ebola virus, is a severe, often fatal disease in humans that can…
11 Oct 19
TECLens' proven CXLens will provide patients with a comfortable, non-invasive alternative to the treatment of ectatic disorders
10 Oct 19
The syndromic test has been designed to run on-demand using the automated Novodiag system
09 Oct 19
The FDA awarded the grants through the Orphan Products Clinical Trials Grants Program, funded by Congress to encourage…
09 Oct 19
Ninth paragraph, first sentence of the release should read: In the group of more than 20 cancer types,…
09 Oct 19
The agreement grants QIAGEN non-exclusive rights to develop and globally commercialize IVD kits to be used together with…
04 Oct 19
Dante Labs to use Illumina Technology to offer consumer access to whole genome sequencing for disease and health…
04 Oct 19
The REMEDIAL III Clinical study demonstrated that RenalGuard Therapy is more effective in preventing the composite of CI-AKI…
01 Oct 19
Inscripta introduced benchtop platform for digital genome engineering, featuring software, consumables, an instrument, and assays for precisely engineering…